Transcriptional reprogramming of natural killer cells by vaccinia virus shows both distinct and conserved features with mCMV
Abstract
Natural killer (NK) cells have an established role in controlling poxvirus infection and there is a growing interest to exploit their capabilities in the context of poxvirus-based oncolytic therapy and vaccination. How NK cells recognise poxvirus-infected cells to become activated remains unclear. To address this knowledge gap, we studied the NK cell response to vaccinia virus (VACV) in vivo, using a systemic infection murine model. We found broad alterations in NK cells transcriptional activity in VACV-infected mice, consistent with both direct target cell recognition and cytokine exposure. There were also alterations in the expression levels of specific NK surface receptors (NKRs), including the Ly49 family and SLAM receptors, as well as upregulation of memory-associated NK markers. Despite the latter observation, adoptive transfer of NK memory populations did not confer protection from re-infection. Comparison with the NK cell response to murine cytomegalovirus (MCMV) infection highlighted common features, but also distinct NK transcriptional programmes initiated by VACV. Finally, there was a clear overlap between the NK transcriptional response in humans vaccinated with an attenuated VACV, modified vaccinia Ankara (MVA), demonstrating conservation between the NK response in these different host species. Overall, this study provides new data about NK cell activation, function, and homeostasis during VACV infection, and may have implication for the design of VACV-based therapeutics.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A single episode of CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire
N. Hassan, S. Eldershaw, … P. Moss·bioRxiv·Feb 28, 2022
- Oncolytic virus treatment differentially affects the CD56dim and CD56bright NK cell subsets in vivo and regulates a spectrum of human NK cell activity
M. Wantoch, E. B. Wilson, … G. P. Cook·bioRxiv·Dec 16, 2020
- Dynamic changes in natural killer cell subset frequencies in the absence of cytomegalovirus infection
I. Gyurova, H. Schlums, … S. N. Waggoner·bioRxiv·Oct 28, 2019
- Natural killer cell immunosuppressive function requires CXCR3-dependent redistribution within lymphoid tissues
A. Ali, L. M. Canaday, … S. N. Waggoner·bioRxiv·May 11, 2021
- Zika virus induces persistent phenotypic changes in natural killer cells distinct from dengue virus infection
Trisha R. Barnard, Noah G. Cruz, … Catherine A. Blish·bioRxiv·Sep 15, 2025
- Receptor-guided engineering of oncolytic vaccinia creates a synthetic support niche for off-the-shelf NK cell therapy
Reza Rezaei, Zhiyang Gan, … Neil C. Sheppard·bioRxiv·Nov 9, 2026